东亚药业(605177)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

605177 东亚药业

已收盘 04-30 15:00:00

{"stockData":{"symbol":"605177","market":"SH","secType":"STK","nameCN":"东亚药业","latestPrice":26.51,"timestamp":1714460400000,"preClose":26.37,"halted":0,"volume":2177880,"delay":0,"floatShares":113999999,"shares":113999999,"eps":1.0746,"marketStatus":"已收盘","marketStatusCode":5,"change":0.14,"latestTime":"04-30 15:00:00","open":26.21,"high":27.43,"low":25.77,"amount":58159400,"amplitude":0.063,"askPrice":26.53,"askSize":37,"bidPrice":26.51,"bidSize":39,"shortable":0,"etf":0,"ttmEps":1.0746,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1714959000000},"adr":0,"adjPreClose":26.37,"symbolType":"stock","openAndCloseTimeList":[[1714440600000,1714447800000],[1714453200000,1714460400000]],"highLimit":29.01,"lowLimit":23.73,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":113600920,"pbRate":1.59,"roa":"--","roe":"1.19%","epsLYR":1.07,"committee":-0.095238,"marketValue":3012000000,"floatMarketCap":3012000000,"peRate":24.669645,"changeRate":0.0053,"turnoverRate":0.0192,"status":0},"requestUrl":"/m/hq/s/605177","defaultTab":"news","newsList":[{"id":"2431365247","title":"东亚药业04月30日获主力加仓367万元 环比增加1429.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2431365247","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2431365247?lang=zh_cn&edition=full","pubTime":"2024-04-30 15:17","pubTimestamp":1714461473,"startTime":"0","endTime":"0","summary":"04月30日, 东亚药业股价涨0.53%，报收26.51元，成交金额5815万元，换手率1.92%，振幅6.30%，量比1.42。东亚药业今日主力资金净流入367万元，上一交易日主力净流入24万元，今日环比增加1429.17%。该股近5个交易日上涨0.45%，主力资金累计净流入221万元；近20日主力资金累计净流入1.07亿元，其中净流入天数为15日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024043015250687c2a86f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024043015250687c2a86f&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2431331638","title":"图解东亚药业一季报：第一季度单季净利润同比增3.53%","url":"https://stock-news.laohu8.com/highlight/detail?id=2431331638","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2431331638?lang=zh_cn&edition=full","pubTime":"2024-04-29 17:33","pubTimestamp":1714383230,"startTime":"0","endTime":"0","summary":"证券之星消息，东亚药业2024年一季报显示，公司主营收入3.53亿元，同比下降4.63%；归母净利润2403.92万元，同比上升3.53%；扣非净利润2037.66万元，同比下降9.58%；负债率40.58%，投资收益189.83万元，财务费用-116.6万元，毛利率25.4%。财报数据概要请见下图:以上内容由证券之星根据公开信息整理，由算法生成（网信算备310104345710301240019号），与本站立场无关，如数据存在问题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404291747028b616be1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404291747028b616be1&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2431401001","title":"东亚药业(605177.SH)发布一季度业绩 净利润2403.92万元 同比增长3.53%","url":"https://stock-news.laohu8.com/highlight/detail?id=2431401001","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2431401001?lang=zh_cn&edition=full","pubTime":"2024-04-29 15:46","pubTimestamp":1714376768,"startTime":"0","endTime":"0","summary":"智通财经APP讯，东亚药业(605177.SH)披露2024年第一季度报告，该公司报告期实现营业收入3.53亿元，同比下降4.63%。归属于上市公司股东的净利润2403.92万元，同比增长3.53%。归属于上市公司股东的扣除非经常性损益的净利润2037.66万元，同比下降9.58%。基本每股收益为0.21元/股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1114035.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2429102800","title":"东亚药业2023年业绩平稳增长，营收首次突破13亿","url":"https://stock-news.laohu8.com/highlight/detail?id=2429102800","media":"览富财经网","top":-1,"share":"https://www.laohu8.com/m/news/2429102800?lang=zh_cn&edition=full","pubTime":"2024-04-24 14:20","pubTimestamp":1713939602,"startTime":"0","endTime":"0","summary":"2024年4月23日晚间，东亚药业披露2023年年度报告。在此基础上，得益于该公司“原料药+制剂”一体化战略加速落地，东亚药业经营规模持续扩大，2023年营业收入首次突破13亿大关。分产品来看，2023年，旗下β-内酰胺类抗菌药仍是营收主力，业务规模进一步扩张。2023年，东亚药业全年共计投入研发费用8173.76万元，同比大幅增长81.85％。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404241422438b4d90c3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404241422438b4d90c3&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429179249","title":"东亚药业大跌5.12% 2023年年报净利润上升16.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2429179249","media":"智选洞察","top":-1,"share":"https://www.laohu8.com/m/news/2429179249?lang=zh_cn&edition=full","pubTime":"2024-04-24 09:42","pubTimestamp":1713922951,"startTime":"0","endTime":"0","summary":"04月24日，东亚药业股价大幅下跌，截至09点42分，东亚药业下跌5.12%，报25.04元/股，成交864万元，换手率0.30%。消息解读东亚药业2023年年报显示，公司主营收入13.56亿元，同比上升15.0%；归母净利润1.21亿元，同比上升16.11%；扣非净利润1.08亿元，同比上升15.31%。资金动向截止发稿，东亚药业获得主力净流入29万元，其中超大单流入53万元，大单流出23万元。主营业务及业绩东亚药业公司主营业务为化学原料药、医药中间体的研发、生产和销售。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404240952347922d071&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404240952347922d071&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429275421","title":"一图看懂2023年东亚药业财报","url":"https://stock-news.laohu8.com/highlight/detail?id=2429275421","media":"新浪财经","top":-1,"share":"https://www.laohu8.com/m/news/2429275421?lang=zh_cn&edition=full","pubTime":"2024-04-24 08:20","pubTimestamp":1713918000,"startTime":"0","endTime":"0","summary":"海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：张恒星","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/y/2024-04-24/doc-inaswtph8844680.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/y/2024-04-24/doc-inaswtph8844680.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2429119460","title":"东亚药业2023年净利1.21亿同比增长16.11% 董事长池正明薪酬187.97万","url":"https://stock-news.laohu8.com/highlight/detail?id=2429119460","media":"挖贝网","top":-1,"share":"https://www.laohu8.com/m/news/2429119460?lang=zh_cn&edition=full","pubTime":"2024-04-23 20:40","pubTimestamp":1713876013,"startTime":"0","endTime":"0","summary":"挖贝网4月23日，东亚药业 近日发布2023年年度报告，报告期内公司实现营业收入1,356,448,097.16元，同比增长15%；归属于上市公司股东的净利润121,249,399.50元，同比增长16.11%。公告显示，报告期内董事、监事、高级管理人员报酬合计752.85万元。董事长池正明从公司获得的税前报酬总额187.97万元，董事、总经理池骋从公司获得的税前报酬总额130.49万元，财务负责人王小敏从公司获得的税前报酬总额73万元。本次利润分配预案尚需提交本公司2023年年度股东大会审议通过。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404232043048b4a9702&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404232043048b4a9702&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429638471","title":"图解东亚药业年报：第四季度单季净利润同比减17.69%","url":"https://stock-news.laohu8.com/highlight/detail?id=2429638471","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2429638471?lang=zh_cn&edition=full","pubTime":"2024-04-23 16:47","pubTimestamp":1713862048,"startTime":"0","endTime":"0","summary":"证券之星消息，东亚药业2023年年报显示，公司主营收入13.56亿元，同比上升15.0%；归母净利润1.21亿元，同比上升16.11%；扣非净利润1.08亿元，同比上升15.31%；其中2023年第四季度，公司单季度主营收入3.52亿元，同比上升8.28%；单季度归母净利润3568.7万元，同比下降17.69%；单季度扣非净利润2968.17万元，同比下降28.06%；负债率39.72%，投资收益702.88万元，财务费用-791.0万元，毛利率26.64%。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042300031167.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2429159168","title":"东亚药业最新公告：2023年净利同比增长16.11% 拟10派3.3元","url":"https://stock-news.laohu8.com/highlight/detail?id=2429159168","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2429159168?lang=zh_cn&edition=full","pubTime":"2024-04-23 16:35","pubTimestamp":1713861354,"startTime":"0","endTime":"0","summary":"东亚药业发布2023年年度报告，实现营业收入13.56亿元，同比增长15.00%；净利润1.21亿元，同比增长16.11%；基本每股收益1.07元。公司拟向全体股东每10股派发现金红利3.30元（含税）。以上内容由证券之星根据公开信息整理，由算法生成（网信算备310104345710301240019号），与本站立场无关，如数据存在问题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042300030316.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2429150876","title":"东亚药业将于5月14日召开股东大会，审议2023年度财务决算报告等议案","url":"https://stock-news.laohu8.com/highlight/detail?id=2429150876","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2429150876?lang=zh_cn&edition=full","pubTime":"2024-04-23 16:06","pubTimestamp":1713859584,"startTime":"0","endTime":"0","summary":"金融界4月23日消息，东亚药业发布公告，将于2024年5月14日召开年度股东大会，网络投票同日进行。股权登记日为5月7日，当日收市后持有东亚药业股票的投资者可以参与投票。会议地点：浙江省台州市黄岩区劳动北路118号总商会大厦23层公司会议室。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042316072387a528f7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042316072387a528f7&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429015082","title":"注意！东亚药业将于5月14日召开股东大会","url":"https://stock-news.laohu8.com/highlight/detail?id=2429015082","media":"每日经济新闻","top":-1,"share":"https://www.laohu8.com/m/news/2429015082?lang=zh_cn&edition=full","pubTime":"2024-04-23 15:54","pubTimestamp":1713858896,"startTime":"0","endTime":"0","summary":"每经AI快讯，东亚药业 4月23日发布公告称，2024年5月14日14点00分，公司将在浙江省台州市黄岩区劳动北路118号总商会大厦23层公司会议室召开2023年年度股东大会。本次股东大会将审议《关于2023年度董事会工作报告的议案》等议案，2024年5月7日收市后登记在册的股东可现场参会投票，或通过交易所投票系统行使表决权。2023年1至12月份，东亚药业的营业收入构成为：医药化工占比99.57%。截至发稿，东亚药业市值为30亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404231608498b49aaaf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404231608498b49aaaf&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429154951","title":"东亚药业(605177.SH)发布2023年度业绩，净利润1.21亿元 同比增加16.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2429154951","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2429154951?lang=zh_cn&edition=full","pubTime":"2024-04-23 15:38","pubTimestamp":1713857928,"startTime":"0","endTime":"0","summary":"智通财经APP讯，东亚药业(605177.SH)发布2023年年度业绩报告，报告期内公司实现营业收入13.56亿元，同比增加15%;归属于上市公司股东的净利润1.21亿元，同比增加16.11%;归属于上市公司股东的扣除非经常性损益的净利润1.08亿元，同比增加15.31%;基本每股收益1.07元，公司拟向全体股东每10股派发现金红利3.30元(含税)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1107441.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2429828910","title":"东亚药业(605177)4月20日股东户数0.97万户，较上期减少5.63%","url":"https://stock-news.laohu8.com/highlight/detail?id=2429828910","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2429828910?lang=zh_cn&edition=full","pubTime":"2024-04-22 17:05","pubTimestamp":1713776754,"startTime":"0","endTime":"0","summary":"证券之星消息，近日东亚药业披露，截至2024年4月20日公司股东户数为9676.0户，较4月10日减少577.0户，减幅为5.63%。在化学制药行业个股中，东亚药业股东户数低于行业平均水平，截至4月20日，化学制药行业平均股东户数为3.36万户。从股价来看，2024年4月10日至2024年4月20日，东亚药业区间涨幅为11.81%，在此期间股东户数减少577.0户，减幅为5.63%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042200019155.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2429912885","title":"东亚药业最新公告：厄多司坦原料药获得韩国原料药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2429912885","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2429912885?lang=zh_cn&edition=full","pubTime":"2024-04-22 16:27","pubTimestamp":1713774458,"startTime":"0","endTime":"0","summary":"东亚药业公告，公司近日收到韩国食品药品监督管理局（韩国MFDS）原料药品注册证书，产品名称为厄多司坦。公司厄多司坦原料药获得韩国原料药品注册证书，标志着公司厄多司坦原料药获得了在韩国的准入资格，将对公司拓展韩国的医药市场带来积极的影响，从而促进公司厄多司坦原料药在其他海外市场的销售。以上内容由证券之星根据公开信息整理，由算法生成（网信算备310104345710301240019号），与本站立场无关，如数据存在问题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042200016110.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2429145449","title":"东亚药业最新筹码趋于集中","url":"https://stock-news.laohu8.com/highlight/detail?id=2429145449","media":"证券时报网","top":-1,"share":"https://www.laohu8.com/m/news/2429145449?lang=zh_cn&edition=full","pubTime":"2024-04-22 16:26","pubTimestamp":1713774383,"startTime":"0","endTime":"0","summary":"证券时报网讯，东亚药业4月22日在交易所互动平台中披露，截至4月20日公司股东户数为9676户，较上期（4月10日）减少577户，环比降幅为5.63%。证券时报•数据宝统计，截至发稿，东亚药业收盘价为26.10元，下跌1.88%，本期筹码集中以来股价累计上涨9.71%。具体到各交易日，5次上涨，3次下跌。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042216262887a07f25&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042216262887a07f25&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429691153","title":"东亚药业：产品取得注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2429691153","media":"每日经济新闻","top":-1,"share":"https://www.laohu8.com/m/news/2429691153?lang=zh_cn&edition=full","pubTime":"2024-04-22 15:57","pubTimestamp":1713772661,"startTime":"0","endTime":"0","summary":"东亚药业（SH 605177，收盘价：26.1元）4月22日晚间发布公告称，近日，浙江东亚药业股份有限公司收到韩国食品药品监督管理局原料药品注册证书。产品名称为“厄多司坦”。2022年1至12月份，东亚药业的营业收入构成为：医药化工占比99.55%。东亚药业的董事长是池正明，男，67岁，学历背景为大专；总经理是池骋，男，40岁，学历背景为本科。截至发稿，东亚药业市值为30亿元。文章来源：每日经济新闻原标题：东亚药业：产品取得注册证","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404221609098b452a30&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404221609098b452a30&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429150539","title":"东亚药业(605177.SH)：厄多司坦原料药获得韩国原料药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2429150539","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2429150539?lang=zh_cn&edition=full","pubTime":"2024-04-22 15:38","pubTimestamp":1713771501,"startTime":"0","endTime":"0","summary":"智通财经APP讯，东亚药业 发布公告，近日，公司收到韩国食品药品监督管理局原料药品注册证书。目前国内生产厄多司坦原料药的企业只有包括扬子江药业集团、西安海欣制药等少数几家厂商在生产。公司厄多司坦原料药获得韩国原料药品注册证书，标志着公司厄多司坦原料药获得了在韩国的准入资格，将对公司拓展韩国的医药市场带来积极的影响，从而促进公司厄多司坦原料药在其他海外市场的销售。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1106415.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2426127444","title":"东亚药业04月12日主力资金流入1780万元 连续7日加仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2426127444","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426127444?lang=zh_cn&edition=full","pubTime":"2024-04-12 15:19","pubTimestamp":1712906363,"startTime":"0","endTime":"0","summary":"04月12日, 东亚药业股价涨1.49%，报收25.12元，成交金额9813万元，换手率3.45%，振幅4.44%，量比1.27。东亚药业今日主力资金净流入1780万元，连续7日净流入，上一交易日主力净流入1099万元，今日环比增加61.97%。该股近5个交易日上涨10.42%，主力资金累计净流入5563万元；近20日主力资金累计净流入6914万元，其中净流入天数为10日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240412154008876d67a2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240412154008876d67a2&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2424060668","title":"东亚药业：第一季度“东亚转债”转股920股 累计转股920股","url":"https://stock-news.laohu8.com/highlight/detail?id=2424060668","media":"每日经济新闻","top":-1,"share":"https://www.laohu8.com/m/news/2424060668?lang=zh_cn&edition=full","pubTime":"2024-04-02 16:46","pubTimestamp":1712047561,"startTime":"0","endTime":"0","summary":"截至2024年3月31日，累计已有人民币约2.3万元“东亚转债”转为公司A股普通股，累计转股股数为920股，占“东亚转债”转股前公司已发行普通股股份总额的0.0008%。2022年1至12月份，东亚药业的营业收入构成为：医药化工占比99.55%。东亚药业的董事长是池正明，男，67岁，学历背景为大专；总经理是池骋，男，40岁，学历背景为本科。截至发稿，东亚药业市值为26亿元。文章来源：每日经济新闻东亚药业：第一季度“东亚转债”转股920股，累计转股920股","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404021649098ae7c2a6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404021649098ae7c2a6&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2424706460","title":"东亚药业(605177.SH)：截止3月31日累计回购1.91%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2424706460","media":"格隆汇资讯","top":-1,"share":"https://www.laohu8.com/m/news/2424706460?lang=zh_cn&edition=full","pubTime":"2024-04-02 16:18","pubTimestamp":1712045895,"startTime":"0","endTime":"0","summary":"格隆汇4月2日丨东亚药业(605177.SH)公布，截止2024年3月31日，公司通过集中竞价交易方式累计回购股份217.0103万股，已回购股份占公司总股本的比例为1.91%，成交的最高价为32.68元/股，最低价为15.47元/股，已支付的总金额为5,499.217944万元（不含交易费用）。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404021618558ae7a0d8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404021618558ae7a0d8&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2020-11-25","address":"浙江省台州市三门县浦坝港镇沿海工业城","stockEarnings":[{"period":"1week","weight":0.0045},{"period":"1month","weight":0.2813},{"period":"3month","weight":0.3176},{"period":"6month","weight":-0.1271},{"period":"1year","weight":0.0792},{"period":"ytd","weight":0.0011}],"companyName":"浙江东亚药业股份有限公司","boardCode":"AI0027","perCapita":"11740股","boardName":"医药制造业","registeredCapital":"11360万元","compareEarnings":[{"period":"1week","weight":0.0274},{"period":"1month","weight":0.0209},{"period":"3month","weight":0.1134},{"period":"6month","weight":0.0317},{"period":"1year","weight":-0.0657},{"period":"ytd","weight":0.0437}],"survey":"　　浙江东亚药业股份有限公司的主营业务是从事化学原料药、医药中间体的研发、生产和销售；公司的主要产品是抗细菌药物、抗胆碱和合成解痉药、皮肤用抗真菌药、其他产品，产品主要涵盖抗细菌类药物（β-内酰胺类和喹诺酮类）、抗胆碱和合成解痉药物（马来酸曲美布汀）、皮肤用抗真菌药物等多个用药领域。公司累计获得授权专利36项，其中发明专利31项，是浙江省专利示范企业。公司多次承担省级重大科技专项、国家火炬计划项目、省重大国际科技专项、省重点高新技术产品开发项目等，多次获得浙江省和台州市科技进步奖等。","serverTime":1714551871640,"listedPrice":31.13,"stockholders":"9676人(较上一季度减少5.63%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"东亚药业(605177)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供东亚药业(605177)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"东亚药业,605177,东亚药业股票,东亚药业股票老虎,东亚药业股票老虎国际,东亚药业行情,东亚药业股票行情,东亚药业股价,东亚药业股市,东亚药业股票价格,东亚药业股票交易,东亚药业股票购买,东亚药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"东亚药业(605177)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供东亚药业(605177)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}